Login / Signup
Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core.
Juliane Grimm
Raj Bhayadia
Lucie Gack
Dirk Heckl
Jan-Henning Klusmann
Published in:
Leukemia (2022)
Keyphrases
</>
acute myeloid leukemia
bone marrow
dendritic cells